|1.||Bielawski, Krzysztof: 4 articles (03/2010 - 07/2006)|
|2.||Bielawska, Anna: 4 articles (03/2010 - 07/2006)|
|3.||Winnicka, Katarzyna: 4 articles (03/2010 - 07/2006)|
|4.||Melzig, M F: 1 article (10/2015)|
|5.||Georgi, S: 1 article (10/2015)|
|6.||Delebinski, C I: 1 article (10/2015)|
|7.||Kopp, B: 1 article (10/2015)|
|8.||Seifert, G: 1 article (10/2015)|
|9.||Twardziok, M: 1 article (10/2015)|
|10.||Kleinsimon, S: 1 article (10/2015)|
|1.||Cardiac Arrhythmias (Arrythmia)
01/01/1979 - "In dogs in vivo the dose of HOE 040 by infusion causing prolongation of PQ or cardiac arrhythmias, resp., was twice the dose necessary of proscillaridin A, the lethal dose was nearly 5 times higher. "
01/01/1979 - "The dose of HOE 040 which by infusion in the guinea pig in vivo precipitates cardiac arrhythmias was 4 times higher than that of proscillaridin A, the lethal dose was 5 times higher. "
01/01/1975 - "The mean arrhythmia percentage at the maximum inotropic effect is dramatically reduced with digoxin, cymarol and proscillaridin. "
01/01/1975 - "The mean arrhythmia percentage occurring at the inotropic maximum is either decreased (gitoxin, 16-epi-gitoxin, digoxin, proscillaridin), unchanged (digitoxin, 16-acetyl-16-epi-gitoxin) or even increased (16-acetyl-gitoxin, cymarol, ouabain). "
|2.||Heart Diseases (Heart Disease)
10/10/1968 - "[Proscillaridin A in the therapy of decompensated heart diseases]."
02/01/1968 - "[On the use of Proscillaridine A in heart diseases in aged subjects]."
12/01/1967 - "[Therapeutic experiences with proscillaridin A in decompensated heart diseases]."
10/01/1966 - "[Changes of the electrocardiograms of heart disease patients caused by the administration of proscillaridin A]."
07/01/1966 - "[Data on the hospital treatment of heart disease patients with proscillaridin A]."
|3.||Pulmonary Heart Disease (Cor Pulmonale)
01/21/1969 - "[Plasmatic turnover and effect on ventricular ejection time (delta I.T.E.) and on the R-1 lead time of the apex cardiogram (t-delta A.C.G.), of proscillaridine A-H 3, intravenously inoculated, in non-compensated cor pulmonale]."
08/31/1967 - "[Theo-talusin in chronic pulmonary heart disease]."
06/01/1966 - "Proscillaridin for cor pulmonale and the senile heart."
12/04/1964 - "[ON CARDIAC THERAPY WITH TALUSIN: WITH SPECIAL REFERENCE TO CHRONIC COR PULMONALE]."
02/21/1970 - "[Clinical and physiopathological observations on the treatment of chronic cor pulmonale with an association of theophylline and proscillaridin A]."
|4.||Breast Neoplasms (Breast Cancer)
03/01/2010 - "The results suggest that conjugation with the G3 PAMAM-NH(2) dendrimer enhances the cytotoxicity of modified digoxin and proscillaridin Aboth in MCF-7 and in MDA-MB-231 breast cancer cells. "
03/01/2010 - "Synthesis and cytotoxic activity of G3 PAMAM-NH(2) dendrimer-modified digoxin and proscillaridin A conjugates in breast cancer cells."
06/01/2008 - "Evaluation of the cytotoxicity of these compounds employing an MTT assay and inhibition of [3H]thymidine incorporation into DNA in both MCF-7 and MDA-MB-231 breast cancer cells demonstrated that compound 3, the most active of the series, proved to be only slightly less potent than proscillaridin A. "
06/01/2008 - "Three derivatives of ouabain, digoxin and proscillaridin A containing the carboxylic group instead of the lactone moiety were synthesized and examined for cytotoxicity in human breast cancer cells. "
06/01/2008 - "Antiproliferative activity of derivatives of ouabain, digoxin and proscillaridin A in human MCF-7 and MDA-MB-231 breast cancer cells."
10/10/1998 - "[A case of proscillaridin poisoning]."
05/01/1990 - "The purpose of this study was to evaluate the capacity of specific anti-digoxin Fab fragments to bind to and neutralize scilliroside and proscillaridin in acute poisoning. "
05/01/1990 - "Specific anti-digoxin Fab fragments: an available antidote for proscillaridin and scilliroside poisoning?"
|5.||Immunoglobulin Fab Fragments
|8.||Ouabain (G Strophanthin)
|1.||Heterologous Transplantation (Xenotransplantation)